2:00 PM Revolutionizing Clinical Trial Design for IgA Nephropathy to Overcome Challenges Associated with Slow Disease Progression
Time: 2:00 pm
day: Conference Day 1
Details:
- Exploring surrogate endpoints beyond GFR to capture changes in disease activity earlier in progression
- Advancing innovative trial designs with flexible durations and interim analyses to solidify the evaluation of therapeutic efficacy
- Applying emerging and established biomarkers to identify a variety of patient subgroups for targeted enrolment resulting in small, efficient trials
